Patient Guide: Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 43 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04454658
Status: ACTIVE_NOT_RECRUITING
Condition: Primary Myelofibrosis
Phase: PHASE1

Where You Can Participate

This study is available at 43 locations across the country.

Top locations include:
  • • Sacramento, California
  • • Lebanon, New Hampshire
  • • Buffalo, New York
  • • And 40 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis - Join Clinical Trial NCTNCT04454658

How to Join This Clinical Trial - NCTNCT04454658

Learn how to participate in this PHASE1 trial studying an investigational therapy for Primary Myelofibrosis. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Primary Myelofibrosis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Primary Myelofibrosis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04454658 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 43 locations. Find a study site near you:

Clinical Research Site

Sacramento, California 95817 - United States

Status: Contact for availability

Clinical Research Site

Lebanon, New Hampshire 03756 - United States

Status: Contact for availability

Clinical Research Site

Buffalo, New York 14263 - United States

Status: Contact for availability

Clinical Research Site

New York, New York 10029 - United States

Status: Contact for availability

Clinical Research Site

New York, New York 10065 - United States

Status: Contact for availability

Clinical Research Site

Canton, Ohio 44718 - United States

Status: Contact for availability

Clinical Research Site

Oklahoma City, Oklahoma 73104-5418 - United States

Status: Contact for availability

Clinical Research Site

Portland, Oregon 97239 - United States

Status: Contact for availability

Clinical Research Site

Dallas, Texas 75246-2003 - United States

Status: Contact for availability

Clinical Research Site

Seattle, Washington 98108-1597 - United States

Status: Contact for availability

And 33 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Primary Myelofibrosis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships